Dr. Bruce Johnson’s Research

The University of Pittsburgh has remained at the forefront of lung transplant clinical research since the field began. Dr. Johnson has been contributing to this literature since 1993 and he has participated in many of the seminal manuscripts including the landmark trial of inhaled cyclosporine (Iacono et al, N Engl J Med 2006) which proved the efficacy of this therapy for prevention of lung transplant rejection. He is currently leading a multicenter phase III trial to confirm the findings of this trial and he actively participates in many other NIH and industry sponsored clinical trials.

Division of PACCM
Academic Offices

NW 628 UPMC Montefiore
3459 Fifth Avenue
Pittsburgh, PA 15213
412-692-2210

Patient Care and Referral

Comprehensive Lung Center (CLC)
Falk Medical Building, 4th Floor
3601 Fifth Avenue
Pittsburgh, PA 15213
412-648-6161